• Home
  • APDM Pharmaceuticals Pvt Ltd

APDM Pharmaceuticals Pvt Ltd

About APDM Pharmaceuticals Pvt Ltd

APDM Pharma Pvt Ltd is a closely held private limited company. Promoters of the company is experienced scientist and entrepreneur known in the industry for his knowledge on pharmaceutical development , patenting and pharmacokinetics of pharmaceutical dosage forms and he has vast experience in senior position in India as well as European company ove...

Read more Show less
Certifications
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator
Primary activities
Analytical Services
Contract Manufacturer
Contract Research Organisation
Regulatory Affairs
Contact info
  • 9426628190
  • Website
  • Office No-403, Patron Building, Rajpath Rangoli Road, Prl Colony, Thaltej , Ahmedabad - Gujarat-380054. T - 91-6359 630 171, +91 6359 630 172, 380054, Ahmedabad, india, India
Show contact info Hide contact info

APDM Pharmaceuticals Pvt Ltd Resources (1)

  • APDM company profile

    Brochure APDM company profile

    APDM Pharma Pvt Ltd is a closely held private limited company. Promoters of the company is experienced scientist and entrepreneur known in the industry for his knowledge on pharmaceutical development , patenting and pharmacokinetics of pharmaceutical dosage forms and he has vast experience in senior position in India as well as European company over 29 years. Besides his scientific knowledge and experience, his business acumen is exceptional. His entrepreneurship journey started in 2013 with a startup CRO company FTF Pharma Private Limited. The company expanded till 2020 helping companies file multiple 505b2 products and launching in USA and EU before divesting the start up to a public listed company in 2020. During his previous stint, he filed more than 50 patents for new dosage forms or oral liquid and injectable products.